The following article has been updated to include comments from the company.
The Israeli cosmetics company L’Oreal has developed an ultra-light moisturizer that can help reduce acne symptoms, and that could eventually help prevent and treat acne, the company said in a statement.
The product, the “Super Moisture” moisturizer, was developed with dermatologist Dr. Yossi Dery and dermatologist Zvi Sadeh and was developed in partnership with the Israeli cosmetic company Lush.
L’Orem said it is not only concerned about improving skin health but also the environment, as well as the impact of its products on human health.
“This is the first time a dermatologist has developed a product that can improve acne symptoms and prevent acne-related conditions,” the company added.
The company said it intends to commercialize the Super Moisturizer product commercially by the end of 2019.
The company said the SuperMoisturization product is designed to help prevent the development of new acne-causing bacteria and improve skin’s natural barrier function.
The SuperMoister has been on the market since October, and L’Oréal plans to market it globally.
The brand also announced a partnership with dermatologists in Israel, and it is launching a campaign that will highlight the benefits of treating acne with the SuperMermaid moisturizer.
In addition to the Super Mermaid, the Israeli cosmetics brand also launched a campaign in September featuring a photo of its new product.
The new product, dubbed the “Skin Super Moister,” features a microfiber membrane, which absorbs and neutralizes oil and debris from the skin and provides a barrier for skin to recover from sun damage.
Lush also said it has a “skin-conditioning” program, and the Supermoisturizing products, which it said can help prevent skin irritation and breakouts, can be used for both dry and oily skin.
The SuperMoismans’ new product comes amid a flurry of activity in the Israeli beauty industry as more and more Israelis start to use products to treat skin conditions such as acne and sun damage, and as the number of Israelis living in Jerusalem has more than doubled to about 20,000.
In June, the Jewish Agency announced a $1 million grant to the Israeli company, and in July, the government announced a grant of $1.4 million to L’Ocean.
Lumina Beauty, the third-largest Israeli beauty brand, has launched its first anti-aging product, which is a microdermabrasion product that has been developed to reduce wrinkles and hyperpigmentation in areas such as the nose, chin, cheeks, forehead, and upper lip.
The cosmetics brand said its products are clinically proven, and there are no known side effects and no toxicity data.
The anti-wrinkle product, however, is expected to be approved by the Food and Drug Administration (FDA) in mid-October.
Luma Cosmetics is also partnering with dermatology researchers in Israel to develop a new line of skin treatments that can be applied to the scalp, under the skin, and even on the skin’s surface.
The products, called “Gel Skin Treatment,” are the result of collaboration between the company and dermatologists at the Department of Dermatology of the Weizmann Medical Center.
The two companies are working to develop the gel skin treatment as part of a broader project, according to the company, which also said the gel-based product can help treat hyperpigeonosis, an inherited skin condition that affects about 3 percent of the population in Israel.
Lumena Beauty’s new products also include a “breathing gel” that is used to treat breathing problems, as a result of research conducted by Dr. Shlomo Z. Auerbaum at the Hebrew University of Jerusalem.
Luminas Health Care is the largest cosmetics company in Israel and is also developing products to help treat skin issues such as eczema and psoriasis.
In July, L’Orange unveiled a new anti-inflammatory moisturizer called “Tsunami” that it said will be approved in October by the FDA for use in eczemas.
Lume’s “Facial Protection” facial moisturizer is also being developed to treat facial blemishes, according the company’s statement.
The Japanese cosmetics company, LUSH, has been investing heavily in the health care sector, and announced in July that it had formed a joint venture with dermatological research center and private company, Kishore Group.
The joint venture will create a new cosmetic brand, and Kishor will be responsible for launching new products, the statement said.